{
  "DOI": "10.1007/s10689-020-00212-2",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-020-00212-2",
  "alternative-id": [
    "212"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "25 May 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "8 October 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "14 October 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflicts of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "All procedures performed in this were in accordance with the ethical standards of Comissão de Ética para a Saúde do IPO-Porto (committee’s reference number: CES219-019) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards."
    },
    {
      "group": {
        "label": "Informed consent",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The consent obtained from study participants was written."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Escudeiro",
      "given": "Carla",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pinto",
      "given": "Carla",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vieira",
      "given": "Joana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Peixoto",
      "given": "Ana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pinto",
      "given": "Pedro",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pinheiro",
      "given": "Manuela",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Santos",
      "given": "Catarina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guerra",
      "given": "Joana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lisboa",
      "given": "Susana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Santos",
      "given": "Rui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Silva",
      "given": "João",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Leal",
      "given": "Conceição",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Coimbra",
      "given": "Nuno",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lopes",
      "given": "Paula",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ferreira",
      "given": "Marco",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sousa",
      "given": "Ana B.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-4896-5982",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Teixeira",
      "given": "Manuel R.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        10,
        14
      ]
    ],
    "date-time": "2020-10-14T04:12:57Z",
    "timestamp": 1602648777000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        10,
        14
      ]
    ],
    "date-time": "2021-10-14T01:46:27Z",
    "timestamp": 1634175987000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        6
      ]
    ],
    "date-time": "2024-03-06T21:03:18Z",
    "timestamp": 1709758998364
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2020,
        10,
        14
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2021,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            10,
            14
          ]
        ],
        "date-time": "2020-10-14T00:00:00Z",
        "timestamp": 1602633600000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            10,
            14
          ]
        ],
        "date-time": "2020-10-14T00:00:00Z",
        "timestamp": 1602633600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00212-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-020-00212-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-020-00212-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "173-180",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        10,
        14
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        10,
        14
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/978-1-4614-3676-8_10",
      "author": "D Bakry",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "key": "212_CR1",
      "unstructured": "Bakry D, Malkin D (2013) TP53 germline mutations: genetics of Li–Fraumeni syndrome. In: Hainaut P, Olivier M, Wiman KG (eds) p53 in the clinics. Springer, New York, pp 167–188",
      "volume-title": "p53 in the clinics",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s13402-011-0010-3",
      "author": "P van der Groep",
      "doi-asserted-by": "publisher",
      "first-page": "71",
      "issue": "2",
      "journal-title": "Cell Oncol (Dordr)",
      "key": "212_CR2",
      "unstructured": "van der Groep P, van der Wall E, van Diest PJ (2011) Pathology of hereditary breast cancer. Cell Oncol (Dordr) 34(2):71–88. https://doi.org/10.1007/s13402-011-0010-3",
      "volume": "34",
      "year": "2011"
    },
    {
      "DOI": "10.7326/0003-4819-71-4-747",
      "author": "FP Li",
      "doi-asserted-by": "publisher",
      "first-page": "747",
      "issue": "4",
      "journal-title": "Ann Intern Med",
      "key": "212_CR3",
      "unstructured": "Li FP, Fraumeni JJF (1969) Soft-TISSUE SARCOMAS, BREAST CANCER, AND OTHER NEOPLASMSA FAMILIAL SYNdrome? Ann Intern Med 71(4):747–752. https://doi.org/10.7326/0003-4819-71-4-747",
      "volume": "71",
      "year": "1969"
    },
    {
      "DOI": "10.1200/JCO.2008.16.6959",
      "author": "KD Gonzalez",
      "doi-asserted-by": "publisher",
      "first-page": "1250",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "212_CR4",
      "unstructured": "Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN (2009) Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27(8):1250–1256",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJM200102223440801",
      "author": "I Hedenfalk",
      "doi-asserted-by": "publisher",
      "first-page": "539",
      "issue": "8",
      "journal-title": "N Engl J Med",
      "key": "212_CR5",
      "unstructured": "Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J, Raffeld M, Yakhini Z, Ben-Dor A, Dougherty E, Kononen J, Bubendorf L, Fehrle W, Pittaluga S, Gruvberger S, Loman N, Johannsson O, Olsson H, Sauter G (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344(8):539–548. https://doi.org/10.1056/NEJM200102223440801",
      "volume": "344",
      "year": "2001"
    },
    {
      "DOI": "10.1073/pnas.0932692100",
      "author": "T Sorlie",
      "doi-asserted-by": "publisher",
      "first-page": "8418",
      "issue": "14",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "212_CR6",
      "unstructured": "Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100(14):8418–8423. https://doi.org/10.1073/pnas.0932692100",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/djaa023",
      "author": "C Hu",
      "doi-asserted-by": "publisher",
      "journal-title": "J Natl Cancer Inst",
      "key": "212_CR7",
      "unstructured": "Hu C, Polley EC, Yadav S, Lilyquist J, Shimelis H, Na J, Hart SN, Goldgar DE, Shah S, Pesaran T, Dolinsky JS, LaDuca H, Couch FJ (2020) The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djaa023",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s10549-012-1993-9",
      "author": "S Masciari",
      "doi-asserted-by": "publisher",
      "first-page": "1125",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "212_CR8",
      "unstructured": "Masciari S, Dillon DA, Rath M, Robson M, Weitzel JN, Balmana J, Gruber SB, Ford JM, Euhus D, Lebensohn A, Telli M, Pochebit SM, Lypas G, Garber JE (2012) Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat 133(3):1125–1130. https://doi.org/10.1007/s10549-012-1993-9",
      "volume": "133",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-012-2375-z",
      "author": "MG Rath",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "212_CR9",
      "unstructured": "Rath MG, Masciari S, Gelman R, Miron A, Miron P, Foley K, Richardson AL, Krop IE, Verselis SJ, Dillon DA, Garber JE (2013) Prevalence of germline TP53 mutations in HER2+ breast cancer patients. Breast Cancer Res Treat 139(1):193–198. https://doi.org/10.1007/s10549-012-2375-z",
      "volume": "139",
      "year": "2013"
    },
    {
      "DOI": "10.1186/bcr3172",
      "author": "DS Lee",
      "doi-asserted-by": "publisher",
      "first-page": "R66",
      "issue": "2",
      "journal-title": "Breast Cancer Res",
      "key": "212_CR10",
      "unstructured": "Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH (2012) Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Res 14(2):R66. https://doi.org/10.1186/bcr3172",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cncr.26377",
      "author": "A Melhem-Bertrandt",
      "doi-asserted-by": "publisher",
      "first-page": "908",
      "issue": "4",
      "journal-title": "Cancer",
      "key": "212_CR11",
      "unstructured": "Melhem-Bertrandt A, Bojadzieva J, Ready KJ, Obeid E, Liu DD, Gutierrez-Barrera AM, Litton JK, Olopade OI, Hortobagyi GN, Strong LC, Arun BK (2012) Early onset HER2-positive breast cancer is associated with germline TP53 mutations. Cancer 118(4):908–913. https://doi.org/10.1002/cncr.26377",
      "volume": "118",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmg.2010.078113",
      "author": "JR Wilson",
      "doi-asserted-by": "publisher",
      "first-page": "771",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "212_CR12",
      "unstructured": "Wilson JR, Bateman AC, Hanson H, An Q, Evans G, Rahman N, Jones JL, Eccles DM (2010) A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet 47(11):771–774. https://doi.org/10.1136/jmg.2010.078113",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2002.09.023",
      "author": "SR Lakhani",
      "doi-asserted-by": "publisher",
      "first-page": "2310",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "212_CR13",
      "unstructured": "Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318. https://doi.org/10.1200/JCO.2002.09.023",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cjp2.133",
      "author": "K Packwood",
      "doi-asserted-by": "publisher",
      "first-page": "189",
      "issue": "3",
      "journal-title": "J Pathol Clin Res",
      "key": "212_CR14",
      "unstructured": "Packwood K, Martland G, Sommerlad M, Shaw E, Moutasim K, Thomas G, Bateman AC, Jones L, Haywood L, Evans DG, Birch JM, Alsalmi OA, Henderson A, Poplawski N, Eccles DM (2019) Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study). J Pathol Clin Res 5(3):189–198. https://doi.org/10.1002/cjp2.133",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.1002/humu.24060",
      "author": "C Fortuno",
      "doi-asserted-by": "publisher",
      "first-page": "1555",
      "issue": "9",
      "journal-title": "Hum Mutat",
      "key": "212_CR15",
      "unstructured": "Fortuno C, Mester J, Pesaran T, Weitzel JN, Dolinsky J, Yussuf A, McGoldrick K, Garber JE, Savage SA, Khincha PP, Gareth Evans D, Achatz MI, Nichols KE, Maxwell KN, Schiffman JD, Sandoval R, James PA, Spurdle AB, Consortium L-FEL (2020) Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines. Hum Mutat 41(9):1555–1562. https://doi.org/10.1002/humu.24060",
      "volume": "41",
      "year": "2020"
    },
    {
      "DOI": "10.1002/humu.22981",
      "author": "JT den Dunnen",
      "doi-asserted-by": "publisher",
      "first-page": "564",
      "issue": "6",
      "journal-title": "Hum Mutat",
      "key": "212_CR16",
      "unstructured": "den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 37(6):564–569. https://doi.org/10.1002/humu.22981",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.jmoldx.2017.05.001",
      "author": "P Paulo",
      "doi-asserted-by": "publisher",
      "first-page": "502",
      "issue": "4",
      "journal-title": "J Mol Diagn",
      "key": "212_CR17",
      "unstructured": "Paulo P, Pinto P, Peixoto A, Santos C, Pinto C, Rocha P, Veiga I, Soares G, Machado C, Ramos F, Teixeira MR (2017) Validation of a next-generation sequencing pipeline for the molecular diagnosis of multiple inherited cancer predisposing syndromes. J Mol Diagn 19(4):502–513. https://doi.org/10.1016/j.jmoldx.2017.05.001",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nature15393",
      "author": "A Auton",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "issue": "7571",
      "journal-title": "Nature",
      "key": "212_CR18",
      "unstructured": "Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526(7571):68–74. https://doi.org/10.1038/nature15393",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jmoldx.2016.10.002",
      "author": "MM Li",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "issue": "1",
      "journal-title": "J Mol Diagn",
      "key": "212_CR19",
      "unstructured": "Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, american society of clinical oncology, and college of american pathologists. J Mol Diagn 19(1):4–23. https://doi.org/10.1016/j.jmoldx.2016.10.002",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1002/gcc.22340",
      "author": "MP Silva",
      "doi-asserted-by": "publisher",
      "first-page": "365",
      "issue": "4",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "212_CR20",
      "unstructured": "Silva MP, Barros-Silva JD, Vieira J, Lisboa S, Torres L, Correia C, Vieira-Coimbra M, Martins AT, Jeronimo C, Henrique R, Paulo P, Teixeira MR (2016) NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer. Genes Chromosomes Cancer 55(4):365–374. https://doi.org/10.1002/gcc.22340",
      "volume": "55",
      "year": "2016"
    },
    {
      "DOI": "10.5858/arpa.2018-0902-SA",
      "author": "AC Wolff",
      "doi-asserted-by": "publisher",
      "first-page": "1364",
      "issue": "11",
      "journal-title": "Arch Pathol Lab Med",
      "key": "212_CR21",
      "unstructured": "Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W, Jenkins RB, Press MF, Spears PA, Vance GH, Viale G, McShane LM, Dowsett M (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med 142(11):1364–1382. https://doi.org/10.5858/arpa.2018-0902-SA",
      "volume": "142",
      "year": "2018"
    },
    {
      "DOI": "10.1101/gad.190678.112",
      "author": "WA Freed-Pastor",
      "doi-asserted-by": "publisher",
      "first-page": "1268",
      "issue": "12",
      "journal-title": "Genes Dev",
      "key": "212_CR22",
      "unstructured": "Freed-Pastor WA, Prives C (2012) Mutant p53: one name, many proteins. Genes Dev 26(12):1268–1286. https://doi.org/10.1101/gad.190678.112",
      "volume": "26",
      "year": "2012"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-2935",
      "author": "Y Kakudo",
      "doi-asserted-by": "publisher",
      "first-page": "2108",
      "issue": "6",
      "journal-title": "Cancer Res",
      "key": "212_CR23",
      "unstructured": "Kakudo Y, Shibata H, Otsuka K, Kato S, Ishioka C (2005) Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s. Cancer Res 65(6):2108–2114. https://doi.org/10.1158/0008-5472.CAN-04-2935",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2013.50.9984",
      "author": "AC Wolff",
      "doi-asserted-by": "publisher",
      "first-page": "3997",
      "issue": "31",
      "journal-title": "J Clin Oncol",
      "key": "212_CR24",
      "unstructured": "Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF, American Society of Clinical O, College of American P (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 31(31):3997–4013. https://doi.org/10.1200/JCO.2013.50.9984",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrclinonc.2014.41",
      "author": "KA McBride",
      "doi-asserted-by": "publisher",
      "first-page": "260",
      "issue": "5",
      "journal-title": "Nature Rev Clin Oncol",
      "key": "212_CR25",
      "unstructured": "McBride KA, Ballinger ML, Killick E, Kirk J, Tattersall MH, Eeles RA, Thomas DM, Mitchell G (2014) Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nature Rev Clin Oncol 11(5):260–271. https://doi.org/10.1038/nrclinonc.2014.41",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1093/annonc/mdv592",
      "author": "DM Eccles",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "3",
      "journal-title": "Ann Oncol",
      "key": "212_CR26",
      "unstructured": "Eccles DM, Li N, Handwerker R, Maishman T, Copson ER, Durcan LT, Gerty SM, Jones L, Evans DG, Haywood L, Campbell I (2016) Genetic testing in a cohort of young patients with HER2-amplified breast cancer. Ann Oncol 27(3):467–473. https://doi.org/10.1093/annonc/mdv592",
      "volume": "27",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s40291-013-0020-0",
      "author": "AD Sorrell",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "issue": "1",
      "journal-title": "Mol Diagn Ther",
      "key": "212_CR27",
      "unstructured": "Sorrell AD, Espenschied CR, Culver JO, Weitzel JN (2013) Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions. Mol Diagn Ther 17(1):31–47. https://doi.org/10.1007/s40291-013-0020-0",
      "volume": "17",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10549-017-4531-y",
      "author": "K Schon",
      "doi-asserted-by": "publisher",
      "first-page": "417",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "212_CR28",
      "unstructured": "Schon K, Tischkowitz M (2018) Clinical implications of germline mutations in breast cancer: TP53. Breast Cancer Res Treat 167(2):417–423. https://doi.org/10.1007/s10549-017-4531-y",
      "volume": "167",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2014.59.5728",
      "author": "G Bougeard",
      "doi-asserted-by": "publisher",
      "first-page": "2345",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "212_CR29",
      "unstructured": "Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugieres L, Caron O, Benusiglio PR, Bressac-de Paillerets B, Bonadona V, Bonaiti-Pellie C, Tinat J, Baert-Desurmont S, Frebourg T (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33(21):2345–2352. https://doi.org/10.1200/JCO.2014.59.5728",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s00432-018-2817-z",
      "author": "VD Li",
      "doi-asserted-by": "publisher",
      "first-page": "625",
      "issue": "3",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "212_CR30",
      "unstructured": "Li VD, Li KH, Li JT (2019) TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database. J Cancer Res Clin Oncol 145(3):625–636. https://doi.org/10.1007/s00432-018-2817-z",
      "volume": "145",
      "year": "2019"
    },
    {
      "author": "Y Horio",
      "first-page": "1231",
      "issue": "4",
      "journal-title": "Oncogene",
      "key": "212_CR31",
      "unstructured": "Horio Y, Suzuki H, Ueda R, Koshikawa T, Sugiura T, Ariyoshi Y, Shimokata K, Takahashi T, Takahashi T (1994) Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 9(4):1231–1235",
      "volume": "9",
      "year": "1994"
    },
    {
      "DOI": "10.1007/s10689-009-9251-y",
      "author": "C Pinto",
      "doi-asserted-by": "publisher",
      "first-page": "383",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "212_CR32",
      "unstructured": "Pinto C, Veiga I, Pinheiro M, Peixoto A, Pinto A, Lopes JM, Reis RM, Oliveira C, Baptista M, Roque L, Regateiro F, Cirnes L, Hofstra RM, Seruca R, Castedo S, Teixeira MR (2009) TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset. Fam Cancer 8(4):383–390. https://doi.org/10.1007/s10689-009-9251-y",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1002/humu.10185",
      "author": "JM Varley",
      "doi-asserted-by": "publisher",
      "first-page": "313",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "212_CR33",
      "unstructured": "Varley JM (2003) Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21(3):313–320. https://doi.org/10.1002/humu.10185",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1097/GIM.0b013e31821628b6",
      "author": "S Masciari",
      "doi-asserted-by": "publisher",
      "first-page": "651",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "212_CR34",
      "unstructured": "Masciari S, Dewanwala A, Stoffel EM, Lauwers GY, Zheng H, Achatz MI, Riegert-Johnson D, Foretova L, Silva EM, Digianni L, Verselis SJ, Schneider K, Li FP, Fraumeni J, Garber JE, Syngal S (2011) Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med 13(7):651–657. https://doi.org/10.1097/GIM.0b013e31821628b6",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1111/cge.12525",
      "author": "H Ariffin",
      "doi-asserted-by": "publisher",
      "first-page": "450",
      "issue": "5",
      "journal-title": "Clin Genet",
      "key": "212_CR35",
      "unstructured": "Ariffin H, Chan AS, Oh L, Abd-Ghafar S, Ong GB, Mohamed M, Razali H, Juraida E, Teo SH, Karsa M, Shamsani J, Hainaut P (2015) Frequent occurrence of gastric cancer in Asian kindreds with Li-Fraumeni syndrome. Clin Genet 88(5):450–455. https://doi.org/10.1111/cge.12525",
      "volume": "88",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10689-012-9557-z",
      "author": "JM McCuaig",
      "doi-asserted-by": "publisher",
      "first-page": "607",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "212_CR36",
      "unstructured": "McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D (2012) Routine TP53 testing for breast cancer under age 30: ready for prime time? Fam Cancer 11(4):607–613. https://doi.org/10.1007/s10689-012-9557-z",
      "volume": "11",
      "year": "2012"
    }
  ],
  "reference-count": 36,
  "references-count": 36,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-020-00212-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "20"
}